Zdrowie i gospodarka · 22/05/2019

FDA Releases Draft Guidance on Biosimilar Therapeutic Protein Development

The FDA is releasing a draft guidance on the development of biosimilar therapeutic proteins, outlining the agency's recommendations for comparative analytical studies and quality-related considerations to support a demonstration of biosimilarity to a reference product.